UnitedHealth Shares Jump as Turnaround Shows Progress
By Nicholas G. Miller
Shares of UnitedHealth rose after the company reported first-quarter results well above analysts' expectations, a year after the company reported disappointing earnings that prompted an unprecedented share meltdown.
The stock rose 7.3% to $347 in premarket trading. Through Monday's close, it was down 24% over the past 12 months.
The company reported adjusted earnings of $7.23 a share, well above analysts' forecast of $6.58 a share, according to FactSet.
Revenue came in at $111.7 billion, beating Wall Street's expectation of $109.43 billion.
The company also raised its full-year adjusted earnings guidance by 50 cents a share to more than $18.25 a share, above the FactSet consensus of $17.86.
Chief Executive Stephen Hemsley has been trying to implement a turnaround after taking the helm last May following the stock sell-off. UnitedHealth said it has made changes including replacing almost half of the company's top 100 executives and investing substantially in AI.
Write to Nicholas G. Miller at nicholas.miller@wsj.com.
(END) Dow Jones Newswires
April 21, 2026 08:05 ET (12:05 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular

The 10 Best Dividend Stocks

5 Stocks to Buy After Earnings

2 5-Star Stocks to Buy at Big Discounts

Tech Stocks Suffer Worst Week Since 2020 as Anthropic Faces Day Two Decline

